First Heartland Consultants’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
LHWM
AIC
MWA
MAM
FFA
BCG
VFA
BONH
VAG
WAM
First Heartland Consultants's XBI Position: Q3 2026 in Review
First Heartland Consultants increased its State Street SPDR S&P Biotech ETF (XBI) stake by 8.6% in Q3 2026, buying an estimated $131K and bringing the position to 10,541 shares worth $1.66M. The position accounts for 0.11% of the portfolio, ranked #155.
First Heartland Consultants first reported a position in XBI in Q3 2023 and has held it in 13 quarters since. 39 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- First Heartland Consultants held 10,541 shares of State Street SPDR S&P Biotech ETF worth $1.66M as of Q3 2026.
- First Heartland Consultants bought 832 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $131K.
- State Street SPDR S&P Biotech ETF made up 0.11% of First Heartland Consultants's portfolio in Q3 2026, its #155 holding.
- First Heartland Consultants first reported a position in State Street SPDR S&P Biotech ETF in Q3 2023 and has held it in 13 quarters since.
- 39 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on First Heartland Consultants's 13F filing for Q3 2026, filed 8 Oct 2026.